Diversified Trust Co increased its position in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,453 shares of the company’s stock after purchasing an additional 711 shares during the quarter. Diversified Trust Co’s holdings in Roche were worth $2,130,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in RHHBY. Bard Financial Services Inc. lifted its stake in shares of Roche by 156.8% in the third quarter. Bard Financial Services Inc. now owns 80,500 shares of the company’s stock worth $3,216,000 after buying an additional 49,150 shares in the last quarter. Altrius Capital Management Inc grew its holdings in shares of Roche by 6.0% in the second quarter. Altrius Capital Management Inc now owns 224,804 shares of the company’s stock valued at $7,794,000 after purchasing an additional 12,646 shares in the last quarter. Verity Asset Management Inc. purchased a new position in shares of Roche during the 3rd quarter worth about $253,000. IHT Wealth Management LLC bought a new stake in shares of Roche during the third quarter valued at approximately $236,000. Finally, AlphaMark Advisors LLC bought a new stake in Roche during the third quarter valued at about $149,000.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on RHHBY. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a research report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.
Roche Price Performance
Roche stock opened at $36.45 on Wednesday. The company’s 50 day simple moving average is $36.12 and its 200-day simple moving average is $37.97. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43.
About Roche
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles
- Five stocks we like better than Roche
- Buy P&G Now, Before It Sets A New All-Time High
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Dividend Capture Strategy: What You Need to Know
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Investing in Commodities: What Are They? How to Invest in Them
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.